Newbridge Financial Services Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-30
| Closed | -$382 | – | 1223 |
|
|
2023
Q3 | $382 | Hold |
30
| – | – | ﹤0.01% | 1217 |
|
|
2023
Q2 | $542 | Hold |
30
| – | – | ﹤0.01% | 1257 |
|
|
2023
Q1 | $516 | Hold |
30
| – | – | ﹤0.01% | 1319 |
|
|
2022
Q4 | $666 | Hold |
30
| – | – | ﹤0.01% | 1340 |
|
|
2022
Q3 | $0 | Hold |
30
| – | – | ﹤0.01% | 1414 |
|
|
2022
Q2 | $0 | Hold |
30
| – | – | ﹤0.01% | 1407 |
|
|
2022
Q1 | $0 | Hold |
30
| – | – | ﹤0.01% | 1477 |
|
|
2021
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 1320 |
|
|
2021
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 1253 |
|
|
2021
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 1350 |
|
|
2021
Q1 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 1267 |
|